ClinicalTrials.gov
public full text
Public Domain
Magnetic Stimulation Therapy for Treating Vascular Depression
This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of depression associated with small vascular lesions in the brain (vascular depression).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- McNeill Dysphagia Therapy Program Combined With Transcranial Magnetic Stimulation#839730
- Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)#855251
- Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression#845446
- Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive Disorder#915218
- Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Depression#1046723
Record · ID 1395518
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive